Concepedia

Nicholas A Honigschmidt

NA

Statistics

Publications

5

Citations

142

H-Index

5

Active since

2003

Affiliations

Eli Lilly (United States)(Current)

Nicholas A Honigschmidt is an author at Eli Lilly (United States) specializing in serotonin receptor pharmacology, 5-hydroxytryptamine 1a receptor agonists, and mechanisms of antidepressant action.

Publications per year

2003–2005

5

Publications

5

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 48 citations · Full text

, , +13

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4

Vincent P. Rocco, Patrick Spinazze, Todd J. Kohn et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 33 citations

, , +13

Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 2

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 21 citations

, , +13

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 20 citations

, , +13

Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 20 citations

, , +13

1–5 of 5